Nanologica Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Andreas Bhagwani

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure14.1yrs
CEO ownershipn/a
Management average tenure4yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Oct 10
Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Is Nanologica AB (publ) (STO:NICA) Trading At A 40% Discount?

Jun 12
Is Nanologica AB (publ) (STO:NICA) Trading At A 40% Discount?

Does Nanologica (STO:NICA) Have A Healthy Balance Sheet?

Oct 20
Does Nanologica (STO:NICA) Have A Healthy Balance Sheet?

Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Jun 23
Nanologica (STO:NICA) Is Making Moderate Use Of Debt

Is Nanologica (NGM:NICA) A Risky Investment?

Jan 03
Is Nanologica (NGM:NICA) A Risky Investment?

Is Nanologica (NGM:NICA) Weighed On By Its Debt Load?

Jun 14
Is Nanologica (NGM:NICA) Weighed On By Its Debt Load?

Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%

Feb 23
Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%

CEO Compensation Analysis

How has Andreas Bhagwani's remuneration changed compared to Nanologica's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 88m

Jun 30 2024n/an/a

-SEK 76m

Mar 31 2024n/an/a

-SEK 80m

Dec 31 2023n/an/a

-SEK 75m

Sep 30 2023n/an/a

-SEK 53m

Jun 30 2023n/an/a

-SEK 53m

Mar 31 2023n/an/a

-SEK 51m

Dec 31 2022SEK 3mSEK 2m

-SEK 55m

Sep 30 2022n/an/a

-SEK 56m

Jun 30 2022n/an/a

-SEK 57m

Mar 31 2022n/an/a

-SEK 53m

Dec 31 2021SEK 2mSEK 2m

-SEK 45m

Sep 30 2021n/an/a

-SEK 35m

Jun 30 2021n/an/a

-SEK 28m

Mar 31 2021n/an/a

-SEK 23m

Dec 31 2020SEK 2mSEK 1m

-SEK 22m

Compensation vs Market: Insufficient data to establish whether Andreas's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensation vs Earnings: Andreas's compensation has increased whilst the company is unprofitable.


CEO

Andreas Bhagwani (49 yo)

14.1yrs

Tenure

SEK 2,818,341

Compensation

Mr. Andreas Bhagwani has been Chief Executive Officer of Nanologica AB (publ) since 2011. Mr. Bhagwani is a Co-Founder of Sigrid Therapeutics AB (obesity therapy) and Atrogi AB (diabetes). He is also Co-Fo...


Leadership Team

NamePositionTenureCompensationOwnership
Andreas Bhagwani
Chief Executive Officer14.1yrsSEK 2.82mno data
Eva Osterman
Chief Financial Officer8.1yrsno data0.058%
SEK 116.9k
Åsa Bergström
Chief Operating Officerless than a yearno datano data
Johanna Johansson
Director of IRno datano datano data
P. Dutta
Senior VP of Sales & Senior Advisor of Chromatography4yrsno datano data
Katarina Alenas
Senior Vice President of Chromatography2.9yrsno datano data

4.0yrs

Average Tenure

53.5yo

Average Age

Experienced Management: NICA's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lena Torlegard
Independent Director11.1yrsSEK 222.50k0.0087%
SEK 17.4k
Thomas Eldered
Director4.1yrsSEK 202.50kno data
Gisela Sitbon
Independent Chairman of the Board13.1yrsSEK 320.00k0.030%
SEK 60.8k
Anders Rabbe
Independent Director5.1yrsSEK 195.00k0.015%
SEK 30.4k
Mattias Bengtsson
Independent Director6.1yrsSEK 195.00k0.015%
SEK 29.6k
Alexandra Montgomery
Independent Directorless than a yearno datano data

5.6yrs

Average Tenure

59yo

Average Age

Experienced Board: NICA's board of directors are considered experienced (5.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 00:24
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nanologica AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Filip EinarssonRedeye